David S. Wilkes

Dr. Wilkes, a specialist in pulmonary disease and critical care medicine, currently serves as Dean at the University of Virginia School of Medicine, a position he has held since 2015. He previously served in positions of increasing responsibility at Indiana University School of Medicine, most recently as the Executive Associate Dean for Research Affairs. Dr. Wilkes is the co-founder of ImmuneWorks Inc., a biotechnology start-up company, and has served as its chief scientific officer since 2006. He served as a member of the Board of Scientific Counselors for the National Heart, Lung and Blood Institute; and the National Advisory Council for the National Institute of Allergy, Immunology and Infectious Disease at NIH. Since 2013, he has served as the National Director of the Harold Amos Medical Faculty Development Program of the Robert Wood Johnson Foundation, a program created to increase the number of faculty from historically disadvantaged backgrounds who can achieve senior rank in academic medicine, dentistry, or nursing. In 2020, he was elected to the National Academy of Medicine. Dr. Wilkes currently serves on the board of directors of Baxter International Inc., a leading global medical products company, where he serves on the Quality, Compliance and Technology Committee. He also serves as a member of the board of trustees of Villanova University, and the board of visitors of the Lewis Katz School of Medicine at Temple University. He received his bachelor’s degree in biology from Villanova University and his medical degree from Temple University School of Medicine. He is a military veteran, having served three years as a major in the U.S. Air Force Medical Corps.